Taken in sum, all of the antilipemics, with the exception of niacin, have the potential to cause a deficiency of fat-soluble vitamins (A, D, E, K) in mother's milk and in the nursing infant.
Antilipemic agents are a pharmacologic class that contains 18 drugs.
The only immunoglobulin in the antilipemic class is evolocumab (Repatha), which has no human pregnancy data.
In addition to pharmacological agents such as ACE inhibitors, hormone replacement therapy drugs, many of the drugs used in diabetes treatment, statin class antilipemics
, pathophysiological factors like hyperglycemia, hypertriglyceridemia, smoking, insulin resistance, affect fibrinolytic activity in a positive or negative way (14, 21).